Technologists have developed an in-body microcomputer to improve quality of life for heart failure patients and help them live longer in what they have called a world first.
Created by medical technology company Vectorious, the pea-sized V-LAP sensor sits within the heart and provides real-time data to health professionals. The device, which is powered by digital technology and artificial intelligence, can detect when pressure in the heart elevates and alert doctors in time.
The skin of study participants who consumed lots of grapes developed an increased resistance to UV light.Grapes contain polyphenols, good stuff for repairing skin and fighting inflammation.After their grape adventure, biopsies revealed less skin-cell damage from UV light.The researchers also found that a topical application of a grapeseed extract containing the polyphenol proanthocyanidins inhibited the formation of sunburn cells.https://bigthink.com/surprising-science/grapes-uv-protection?rebelltitem=1#rebelltitem1
MedCU's (https://medcu.com/) copper antimicrobial dressings. The first, and
only, in the world with regulation clearance for commercialisation, holding
both FDA & CE. One of the core properties of copper is the spectrum of antimicrobial efficacy. Copper kills a wide array of microorganisms, including
gram-negative and gram-positive bacteria, fungi and viruses. The biocidal
effect is achieved through several non-specific mechanisms, preventing the
development of copper resistance, allowing copper to be an effective treatment
against antibiotic-resistant microorganisms. For more information about MedCU's antimicrobial wound dressings and to see how it can be applicable to hospitals, diabetic patients, and more, click here:
A weight-loss drug could be repurposed to prevent organ failure in patients in intensive care, research from the University of Auckland and Monash University in Australia shows.Orlistat, marketed in New Zealand as Xenical, can be retooled to treat conditions such as severe acute pancreatitis, severe infection and haemorrhagic shock, according to the study published in the International Journal of Pharmaceutics.Patent filed. Seeking commercial partners.https://doi.org/10.1016/j.ijpharm.2021.120247